Rios Israel 4
4 · SCICLONE PHARMACEUTICALS INC · Filed May 31, 2011
Insider Transaction Report
Form 4
Rios Israel
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2011-05-27+14,971→ 14,971 total→ Common Stock (14,971 underlying)
Footnotes (4)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
- [F3]25% of the restricted stock units will vest on April 5, 2012, April 5, 2013, April 5, 2014, and April 5, 2015, unless the trading window is closed for the Reporting Person on each date, then the vesting date will be deferred until the next date that the trading window is open.
- [F4]25% of the restricted stock units will vest on April 5, 2012, April 5, 2013, April 5, 2014 and April 5, 2015, unless the trading window is closed for the Reporting Person on that date, then the vesting date will be deferred until the next date that the trading window is open.